WARPTECHNEWS · LAB
HomeAIBusinessTechArchive
WARPTECH LAB NEWS

Warptech Lab News aggrega le notizie più rilevanti da oltre 700 fonti internazionali, con classificazione AI, TL;DR sintetici e timeline cluster su singole storie.

Navigazione

  • Home
  • Archivio
  • Editor's Brief
  • Cerca
  • Il tuo account
  • Newsletter tech/AI

Informazioni legali

  • Privacy Policy
  • Termini di servizio
  • Cookie Policy

© 2026 Sparktech S.R.L. — Tutti i diritti riservati. Sito gestito e manutenuto da Sparktech S.R.L.

Sede legale: Corso Libertà 55, 13100 Vercelli (VC), Italia · P.IVA / C.F. 02835910023 · Contatti: admin@warptechlab.com

Home
Storia in 1 fonti

Tenax Therapeutics (TENX) Gets a Buy from LifeSci Capital

In a report released today, Gaurav Maini from LifeSci Capital maintained a Buy rating on Tenax Therapeutics, with a price target of $35.00.TipRa...

Raccontata damarkets.businessinsider.com

Timeline cronologica

  1. sabato 11 luglio 2026·markets.businessinsider.com

    Neurogene (NGNE) Receives a Buy from LifeSci Capital

    In a report released today, Patrick Dolezal from LifeSci Capital maintained a Buy rating on Neurogene, with a price target of $65.00.TipRanks We...

  2. sabato 11 luglio 2026·markets.businessinsider.com

    LifeSci Capital Remains a Buy on Prime Medicine, Inc. (PRME)

    LifeSci Capital analyst Cory Jubinville, PhD maintained a Buy rating on Prime Medicine, Inc. today and set a price target of $6.00.TipRanks Welc...

  3. sabato 11 luglio 2026·markets.businessinsider.com

    Tenax Therapeutics (TENX) Gets a Buy from LifeSci Capital

    In a report released today, Gaurav Maini from LifeSci Capital maintained a Buy rating on Tenax Therapeutics, with a price target of $35.00.TipRa...